PLoS Pathogens (May 2022)

CD4 T-cell depletion prevents Lassa fever associated hearing loss in the mouse model.

  • Junki Maruyama,
  • Rachel A Reyna,
  • Megumi Kishimoto-Urata,
  • Shinji Urata,
  • John T Manning,
  • Nantian Harsell,
  • Rebecca Cook,
  • Cheng Huang,
  • Janko Nikolich-Zugich,
  • Tomoko Makishima,
  • Slobodan Paessler

DOI
https://doi.org/10.1371/journal.ppat.1010557
Journal volume & issue
Vol. 18, no. 5
p. e1010557

Abstract

Read online

Lassa virus (LASV) is the causative agent of Lassa fever (LF), which presents as a lethal hemorrhagic disease in severe cases. LASV-induced hearing loss in survivors is a huge socioeconomic burden, however, the mechanism(s) leading to hearing loss is unknown. In this study, we evaluate in a mouse LF model the auditory function using auditory brainstem response (ABR) and distortion product otoacoustic emissions (DPOAE) to determine the mechanisms underlying LASV-induced hearing loss. In the process, we pioneered measures of ABR and DPOAE tests in rodents in biosafety level 4 (BSL-4) facilities. Our T cell depletion studies demonstrated that CD4 T-cells play an important role in LASV-induced hearing loss, while CD8 T-cells are critical for the pathogenicity in the acute phase of LASV infection. Results presented in this study may help to develop future countermeasures against acute disease and LASV-induced hearing loss.